not tagged
chemocentryx
['solid tumor', 'chemocentryx']
at there s an update on #ccx559, an investigational, orally administered small molecule pd-l1 inhibitor, from an ongoing phase 1 dose escalation study in patients with advanced solid tumors. #asco22 
A biopharmaceutical company developing new medications targeted at inflammatory & autoimmune diseases & cancer. 
Our Twitter guidelines: https://t.co/7UkCT5gujx